ACM.NYSEAecom

Form 4: AECOM President Poloni Reports Stock Transactions

Sentiment:

Insider Transaction Report


📋All filings for Aecom

AECOM President Lara Poloni reported significant stock transactions, including vesting of restricted stock units and sales under a 10b5-1 plan.

Summary

  • Lara Poloni, President of AECOM, reported multiple transactions involving the company's common stock.
  • On December 15, 2025, 10,040 restricted stock units (RSUs) granted on December 15, 2022, vested, resulting in the acquisition of 10,040 shares of common stock at a price of $0.
  • An additional 16,334 restricted stock units were acquired on December 15, 2025, as an annual grant, which are scheduled to vest in full on December 15, 2028.
  • 23,615 shares were acquired on December 15, 2025, pursuant to AECOM's Performance Earnings Program under the 2020 Stock Incentive Plan.
  • 13,425 shares of common stock were withheld by AECOM on December 15, 2025, at a price of $97.96 to satisfy tax withholding obligations related to the vesting of RSUs and shares from the Performance Earnings Program.
  • On December 17, 2025, Poloni sold 17,340 shares of common stock at $97.01 per share.
  • Also on December 17, 2025, an additional 193 shares were sold at a weighted average price of $98.35, with transactions ranging from $98.35 to $98.48.
  • All sales on December 17, 2025, were executed under a Rule 10b5-1 trading plan adopted on September 11, 2025.
  • Following these transactions, Poloni directly beneficially owns 149,222 shares of common stock and indirectly owns 108.13 shares through Merrill Lynch under the AECOM Retirement & Savings Plan (RSP).

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of insider stock transactions, primarily related to compensation vesting and pre-planned sales. It does not contain information that would significantly alter the fundamental outlook for the company, hence a neutral sentiment.

Positives

  • Vesting of 10,040 restricted stock units and acquisition of 23,615 shares from the Performance Earnings Program represent realized compensation for the President.
  • The grant of an additional 16,334 restricted stock units demonstrates ongoing long-term incentive compensation aligned with future service.

Negatives

  • The sale of 17,533 shares (17,340 + 193) reduces the direct beneficial ownership of the President in the company.

Risks

  • Insider sales, even when pre-planned, can sometimes be perceived negatively by the market, potentially leading to questions about management's confidence, although these transactions appear routine and compensation-related.

Future Outlook

The filing indicates a future vesting event for 16,334 restricted stock units on December 15, 2028, subject to continued service, which represents a component of future executive compensation.

Industry Context

This Form 4 filing details routine insider stock transactions, which are common occurrences in publicly traded companies. Such transactions, especially those involving vesting of equity awards and subsequent sales under pre-arranged 10b5-1 plans, are standard practice for executive compensation and personal financial management across various industries.

Comparison to Industry Standards

  • The use of a Rule 10b5-1 trading plan for stock sales is a standard corporate governance practice, widely adopted by executives in public companies across industries to mitigate accusations of insider trading by pre-scheduling transactions.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdherenceThe sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025, demonstrating adherence to SEC regulations for insider trading.September 11, 2025Enhances transparency and reduces the risk of insider trading allegations by pre-scheduling transactions.

Stakeholder Impact

  • Shareholders: Provides transparency regarding executive stock ownership and trading activity, which is generally expected for public companies.
  • Employees: Reflects the structure of executive compensation, including equity awards and performance programs.

Next Steps

  • The 16,334 restricted stock units granted on December 15, 2025, are scheduled to vest in full on December 15, 2028, subject to continued service.

Key Dates

DateDescription
September 11, 2025Date the Rule 10b5-1 trading plan was adopted by the Reporting Person.
December 15, 2022Grant date of the restricted stock units that vested on December 15, 2025.
December 15, 2025Date of vesting for 10,040 restricted stock units, acquisition of 16,334 annual grant restricted stock units, acquisition of 23,615 shares from the Performance Earnings Program, and tax withholding for 13,425 shares.
December 17, 2025Date of sales of 17,340 and 193 shares of common stock, and the signature date of the reporting person.
December 15, 2028Vesting date for the 16,334 restricted stock units granted on December 15, 2025.

Recommendation

hold

This Form 4 filing details routine insider stock transactions, including the vesting of equity awards and subsequent sales under a pre-planned 10b5-1 trading plan. Such transactions are common for executive compensation and personal financial management and do not typically signal a change in the company's fundamental performance or outlook. Therefore, the filing itself does not warrant a change in investment recommendation; investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

AECOM, ACM, Form 4, Insider Transaction, Lara Poloni, Restricted Stock Units, 10b5-1 Plan, Stock Sale, Performance Earnings Program, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.